6/11/2025
Author: Designed by FreepikFacial nerve paralysis, also known as Bell’s palsy, is a condition that significantly affects patients’ quality of life. The facial nerve (cranial nerve VII) controls the facial muscles, enabling basic functions such as speaking, eating, and expressing emotions. Damage to this nerve—caused by Bell’s palsy, Ramsay Hunt syndrome, or tumors such as neuromas—can lead to weakness or paralysis of the facial muscles. These symptoms not only hinder daily functioning but may also lead to serious psychological issues such as depression, anxiety, or social isolation. Traditional treatments, such as physical therapy, anti-inflammatory drugs (e.g., corticosteroids), or surgical procedures, have their limitations and often do not ensure full nerve function recovery, especially in severe cases.
That is why scientists worldwide are seeking innovative solutions to improve facial nerve regeneration. One of the most promising research directions is stem cell therapy, which could revolutionize the treatment of facial paralysis.
Current approaches to facial nerve rehabilitation include pharmacotherapy, such as corticosteroids (e.g., prednisone) to reduce inflammation, and physiotherapy to help maintain muscle function. In more severe cases, surgical procedures such as nerve decompression or nerve grafts are used. However, these methods are not always effective, especially in cases of permanent damage where axonal (nerve fiber) regeneration is limited. Furthermore, long-term rehabilitation can be burdensome for patients, requiring regular specialist visits and consistent exercise routines. In response to these challenges, stem cell research is opening new possibilities, offering potentially more effective and less invasive methods for facial nerve regeneration.
Stem cells are unique cells capable of differentiating into various types of cells, including neurons and Schwann cells, which play a key role in peripheral nerve regeneration. Additionally, stem cells secrete growth factors such as brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF), which support neural tissue repair. In the case of the facial nerve, responsible for movement and sensation in the facial area, stem cell therapies may accelerate axonal regeneration, improve nerve conduction, and reduce complications such as synkinesis (abnormal, involuntary muscle movements). Preclinical studies, mostly conducted on animal models, have shown that various types of stem cells have significant potential to restore facial nerve function.
Research into facial nerve regeneration has used various types of stem cells, each exhibiting unique regenerative properties. Below are the key types of stem cells and their effects in preclinical studies:
Olfactory Stem Cells (OSC)
Stem Cells from Exfoliated Deciduous Teeth (SHED)
Adipose-Derived Stem Cells (ADSC)
Bone Marrow-Derived Stem Cells (BMSC)
Dental Pulp Stem Cells (DPC)
Gingival Mesenchymal Stem Cells (GMSC)
Neural Crest Stem Cell-like Cells (NCSC)
Dedifferentiated Fat Cells (DFAT)
Stem cells support facial nerve regeneration in several ways:
Preclinical studies have delivered promising results. For example:
These results indicate that stem cells can significantly enhance facial nerve regeneration in animal models, offering hope for new therapeutic approaches.
Despite promising preclinical results, introducing stem cell therapies into clinical practice faces several challenges:
Ongoing clinical trials are evaluating the safety and efficacy of stem cells like ADSC and BMSC in peripheral nerve regeneration, including facial nerve recovery. For example, research into ADSC for peripheral nerve damage is at an advanced stage, and results may soon provide clinical application data. Moreover, technologies such as 3D bioprinting (e.g., in GMSC) may facilitate the creation of nerve-regenerating structures.
The NeuroFace app supports people undergoing facial rehabilitation by:
We support you on the journey to better facial expression and greater quality of life.
Stem cell therapies represent a breakthrough direction in treating facial nerve paralysis. Preclinical studies have shown that various types of stem cells, such as OSC, SHED, ADSC, BMSC, and DPC, have significant potential to restore facial nerve function through axon regeneration, inflammation reduction, and growth factor secretion. Although challenges remain in safety, standardization, and clinical efficacy, ongoing clinical trials and the development of new technologies offer hope for integrating these therapies into medical practice. In the future, stem cell therapies could not only improve the quality of life for patients with facial nerve paralysis but also open new possibilities for treating other peripheral nerve injuries. Continued research and investment in this field are key to realizing its full potential.
Follow our development and stay updated! Sign up for the newsletter to not miss any news!
